BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 11866271)

  • 1. Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants.
    Teich N; Bauer N; Mössner J; Keim V
    Am J Gastroenterol; 2002 Feb; 97(2):341-6. PubMed ID: 11866271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for human cationic trypsinogen (PRSS1) and trypsinogen inhibitor gene (SPINK1) mutations in a Finnish family with hereditary pancreatitis.
    Räty S; Piironen A; Babu M; Pelli H; Sand J; Uotila S; Nordback I; Herzig KH
    Scand J Gastroenterol; 2007 Aug; 42(8):1000-5. PubMed ID: 17613931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CFTR, PRSS1 and SPINK1 mutations in the development of pancreatitis in Brazilian patients.
    Bernardino AL; Guarita DR; Mott CB; Pedroso MR; Machado MC; Laudanna AA; Tani CM; Almeida FL; Zatz M
    JOP; 2003 Sep; 4(5):169-77. PubMed ID: 14526128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The course of genetically determined chronic pancreatitis.
    Keim V; Witt H; Bauer N; Bodeker H; Rosendahl J; Teich N; Mossner J
    JOP; 2003 Jul; 4(4):146-54. PubMed ID: 12853682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of the serine protease inhibitor, Kazal type 1 gene, in patients with idiopathic chronic pancreatitis.
    Truninger K; Witt H; Köck J; Kage A; Seifert B; Ammann RW; Blum HE; Becker M
    Am J Gastroenterol; 2002 May; 97(5):1133-7. PubMed ID: 12014716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene.
    Felderbauer P; Karakas E; Fendrich V; Bulut K; Horn T; Lebert R; Holland-Letz T; Schmitz F; Bartsch D; Schmidt WE
    Am J Gastroenterol; 2008 Feb; 103(2):368-74. PubMed ID: 18076731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic aspects of chronic pancreatitis: insights into aetiopathogenesis and clinical implications.
    Truninger K; Ammann RW; Blum HE; Witt H
    Swiss Med Wkly; 2001 Oct; 131(39-40):565-74. PubMed ID: 11775491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in a family with heterozygous SPINK1 mutations.
    Felderbauer P; Hoffmann P; Einwächter H; Bulut K; Ansorge N; Schmitz F; Schmidt WE
    BMC Gastroenterol; 2003 Nov; 3():34. PubMed ID: 14641934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).
    Teich N; Le Maréchal C; Kukor Z; Caca K; Witzigmann H; Chen JM; Tóth M; Mössner J; Keim V; Férec C; Sahin-Tóth M
    Hum Mutat; 2004 Jan; 23(1):22-31. PubMed ID: 14695529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel A121T mutation in human cationic trypsinogen associated with hereditary pancreatitis: functional data indicating a loss-of-function mutation influencing the R122 trypsin cleavage site.
    Felderbauer P; Schnekenburger J; Lebert R; Bulut K; Parry M; Meister T; Schick V; Schmitz F; Domschke W; Schmidt WE
    J Med Genet; 2008 Aug; 45(8):507-12. PubMed ID: 18511571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The variable phenotype of the p.A16V mutation of cationic trypsinogen (PRSS1) in pancreatitis families.
    Grocock CJ; Rebours V; Delhaye MN; Andrén-Sandberg A; Weiss FU; Mountford R; Harcus MJ; Niemczyck E; Vitone LJ; Dodd S; Jørgensen MT; Ammann RW; Schaffalitzky de Muckadell O; Butler JV; Burgess P; Kerr B; Charnley R; Sutton R; Raraty MG; Devière J; Whitcomb DC; Neoptolemos JP; Lévy P; Lerch MM; Greenhalf W;
    Gut; 2010 Mar; 59(3):357-63. PubMed ID: 19951905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of CFTR, SPINK1, PRSS1 and AAT mutations in children with acute or chronic pancreatitis.
    Sobczyńska-Tomaszewska A; Bak D; Oralewska B; Oracz G; Norek A; Czerska K; Mazurczak T; Teisseyre M; Socha J; Zagulski M; Bal J
    J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):299-306. PubMed ID: 16954950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis.
    Chandak GR; Idris MM; Reddy DN; Mani KR; Bhaskar S; Rao GV; Singh L
    Gut; 2004 May; 53(5):723-8. PubMed ID: 15082592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic, epidemiological, and clinical aspects of hereditary pancreatitis: a population-based cohort study in Denmark.
    Joergensen MT; Brusgaard K; Crüger DG; Gerdes AM; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 2010 Aug; 105(8):1876-83. PubMed ID: 20502448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of CFTR, PRSS1, and SPINK1 mutations in 381 patients with pancreatitis.
    Keiles S; Kammesheidt A
    Pancreas; 2006 Oct; 33(3):221-7. PubMed ID: 17003641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic aspects of chronic pancreatitis.
    Teich N; Mössner J
    Med Sci Monit; 2004 Dec; 10(12):RA325-8. PubMed ID: 15567996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis.
    Ockenga J; Stuhrmann M; Ballmann M; Teich N; Keim V; Dörk T; Manns MP
    Am J Gastroenterol; 2000 Aug; 95(8):2061-7. PubMed ID: 10950058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mutation and polymorphism of PRSS1 gene in the Chinese patients with hereditary pancreatitis and chronic pancreatitis.
    Liu QC; Gao F; Ou QS; Zhuang ZH; Lin SR; Yang B; Cheng ZJ
    Chin Med J (Engl); 2008 Jan; 121(2):108-11. PubMed ID: 18272034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic counseling for hereditary pancreatitis--the role of molecular genetics testing for the cationic trypsinogen gene, cystic fibrosis and serine protease inhibitor Kazal type 1.
    Ellis I
    Gastroenterol Clin North Am; 2004 Dec; 33(4):839-54. PubMed ID: 15528021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis.
    Drenth JP; te Morsche R; Jansen JB
    Gut; 2002 May; 50(5):687-92. PubMed ID: 11950817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.